McGuire J J, Hsieh P, Bertino J R
Biochem Pharmacol. 1984 Apr 15;33(8):1355-61. doi: 10.1016/0006-2952(84)90192-8.
7-Hydroxymethotrexate, an important metabolite of methotrexate, is a substrate for folylpolyglutamate synthetase (FPGS) isolated from rat liver and several human leukemia cell lines. The substrate activity it displays over a wide range of concentrations (0-200 microM) is nearly equivalent to that of methotrexate. The 7-hydroxy derivative of dichloromethotrexate is also a substrate for FPGS. The pattern of polyglutamate products synthesized by rat liver FPGS was nearly identical with both 7-hydroxymethotrexate and methotrexate. In addition, conversion of MTX polyglutamates to the corresponding 7-hydroxy compounds was demonstrated using partially purified rabbit liver aldehyde oxidase. The rate of conversion was concentration dependent, and the relative rate decreased as the MTX polyglutamate chain length increased. We propose that 7-hydroxymethotrexate polyglutamates may be formed by initial hydroxylation of methotrexate and subsequent polyglutamate formation or by direct hydroxylation of methotrexate polyglutamates. It was further shown that the relative substrate activity of folate analogs for folylpolyglutamate synthetase is dependent on the source of the enzyme.
7-羟基甲氨蝶呤是甲氨蝶呤的一种重要代谢产物,是从大鼠肝脏和几种人类白血病细胞系中分离出的叶酰聚谷氨酸合成酶(FPGS)的底物。它在很宽的浓度范围(0 - 200微摩尔)内表现出的底物活性几乎与甲氨蝶呤相当。二氯甲氨蝶呤的7-羟基衍生物也是FPGS的底物。大鼠肝脏FPGS合成的聚谷氨酸产物模式与7-羟基甲氨蝶呤和甲氨蝶呤几乎相同。此外,使用部分纯化的兔肝脏醛氧化酶证明了甲氨蝶呤聚谷氨酸向相应7-羟基化合物的转化。转化速率取决于浓度,并且随着甲氨蝶呤聚谷氨酸链长度的增加,相对速率降低。我们提出7-羟基甲氨蝶呤聚谷氨酸可能通过甲氨蝶呤的初始羟基化和随后的聚谷氨酸形成,或者通过甲氨蝶呤聚谷氨酸的直接羟基化形成。进一步表明,叶酸类似物对叶酰聚谷氨酸合成酶的相对底物活性取决于酶的来源。